Skip to main
AVNT

Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corp (AVNT) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Avient Corp has experienced a 5% increase in organic sales, with its healthcare segment demonstrating particularly strong performance, achieving a 14% year-over-year growth in the first half of fiscal year 2025 and sustaining double-digit growth for six consecutive quarters. Additionally, four out of nine end markets, which collectively represent 40% of Avient's sales, are showing growth this year, contributing to an overall organic sales increase of approximately 2% for 2025. Despite anticipated negative growth in the consumer end market, the company's diversified product portfolio and strong revenue generation from key sectors indicate a positive financial outlook for Avient.

Bears say

Avient Corp has experienced negative organic sales growth, with a decline of approximately 2% in the first quarter of 2024 followed by fluctuations in growth rates in subsequent quarters, raising concerns about its revenue stability. A weakening demand for chemicals since mid-2025 poses further risks, as recent assessments indicate potential declines in volume for the latter half of 2025. While a depreciating dollar could provide some support, the overarching financial metrics suggest a concerning trend that may impact Avient's future performance negatively.

Avient Corp (AVNT) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Avient Corp (AVNT) Forecast

Analysts have given Avient Corp (AVNT) a Buy based on their latest research and market trends.

According to 6 analysts, Avient Corp (AVNT) has a Buy consensus rating as of Dec 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $45.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $45.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Avient Corp (AVNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.